Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases
Advanced Drug Delivery Reviews · 2023
DOI: 10.1016/j.addr.2023.114870 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023. Verfasst von Noriyasu Hashida und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: nhashida@ophthal.med.osaka-u.ac.jp. Hauptthemen laut MEDLINE: Eye Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 229 Literaturangaben. Gefördert von: Japan Science and Technology Agency, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Effective drug therapy for vitreoretinal disease is a major challenge in the field of ophthalmology; various protective systems, including anatomical and physiological barriers, complicate drug delivery to precise targets. However, as the eye is a closed cavity, it is an ideal target for local administration. Various types of drug delivery systems have been investigated that take advantage of this aspect of the eye, enhancing ocular permeability and optimizing local drug concentrations. Many drugs, mainly anti-VEGF drugs, have been evaluated in clinical trials and have provided clinical benefit to many patients. In the near future, innovative drug delivery systems will be developed to avoid frequent intravitreal administration of drugs and maintain effective drug concentrations for a long period of time. Here, we review the published literature on various drugs and administration routes and current clinical applications. Recent advances in drug delivery systems are discussed along with future prospects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: nhashida@ophthal.med.osaka-u.ac.jp.
- Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), O…
Förderung
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Hashida, N., & Nishida, K. (2023). Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2023.114870
Vancouver
Hashida N, Nishida K. Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases. Advanced Drug Delivery Reviews. 2023. doi:10.1016/j.addr.2023.114870
BibTeX
@article{Hashida2023,
author = {Hashida, Noriyasu and Nishida, Kohji},
title = {Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
doi = {10.1016/j.addr.2023.114870}
}
EUVIMED